Suppr超能文献

下肢动脉硬化所致肢体威胁性缺血的成本因素

Cost factors in limb-threatening ischaemia due to infrainguinal arteriosclerosis.

作者信息

Gupta S K, Veith F J, Ascer E, Flores S A, Gliedman M L

机构信息

Department of Surgery, Montefiore Medical Center/Albert Einstein College of Medicine, New York, NY 10467.

出版信息

Eur J Vasc Surg. 1988 Jun;2(3):151-4. doi: 10.1016/s0950-821x(88)80067-7.

Abstract

Cost factors are an increasingly important aspect of medical care. In the United States, more than 150,000 patients per year have limb-threatening ischaemia due to infrainguinal atherosclerosis. We studied the economic impact of this disease process and its treatment in 313 consecutive patients seen at our hospital between 1979 and 1981. Minimum follow-up was 3 years. Seventy-nine percent of our patients undergoing revascularisation attempts had limb salvage with full function at 1 year and 60% had full function at 3 years. Of the patients who died, 85% died with their limbs intact. The mean patient cost for all 289 arterial reconstructions was $26,194 +/- $876 S.E. ($23,026 +/- $1117 for 166 femoropopliteal bypasses; $30,380 +/- $1349 for 123 distal bypasses). The mean length of stay (LOS) for the reconstruction group was 50 days. In this patient population, the following adverse risk factors were present: Gangrene or necrosis in the foot (72%), age more than 70 (56%), and previous vascular surgery (21%). A significantly higher cost was associated with each of these factors (gangrene, $32,653 +/- $1534; age greater than 70, $28,089 +/- $1235; previous bypass, $29,666 +/- $1962). During the same time period, initial patient costs for 24 patients undergoing primary below-knee amputation and rehabilitation were $27,225 +/- $2896 S.E. Twenty-nine percent of the patients with below-knee amputations never walked again. The nonambulatory patients had a significant continuing expenditure for institutionalisation ($100/day) or home care ($270/week). These facts document the high cost of limb-threatening arteriosclerosis and its treatment by vascular reconstruction or primary below-knee amputation.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

成本因素在医疗保健中变得越来越重要。在美国,每年有超过15万名患者因下肢动脉硬化而面临肢体缺血的威胁。我们研究了1979年至1981年间在我院连续就诊的313例患者中该疾病过程及其治疗的经济影响。最短随访时间为3年。在接受血管重建尝试的患者中,79%在1年时肢体得以挽救且功能完全恢复,60%在3年时功能完全恢复。在死亡的患者中,85%死亡时肢体完好。289例动脉重建的平均患者费用为26,194美元±876美元标准误(166例股腘动脉搭桥为23,026美元±1117美元;123例远端搭桥为30,380美元±1349美元)。重建组的平均住院时间为50天。在这一患者群体中,存在以下不良风险因素:足部坏疽或坏死(72%)、年龄超过70岁(56%)以及既往血管手术史(21%)。这些因素中的每一个都与显著更高的费用相关(坏疽,32,653美元±1534美元;年龄大于70岁,28,089美元±1235美元;既往搭桥,29,666美元±1962美元)。在同一时期,24例接受初次膝下截肢和康复治疗的患者的初始费用为27,225美元±2896美元标准误。29%的膝下截肢患者再也无法行走。非行走患者在机构护理(100美元/天)或家庭护理(270美元/周)方面有持续的高额支出。这些事实证明了肢体威胁性动脉硬化及其通过血管重建或初次膝下截肢治疗的高昂成本。(摘要截选至250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验